Dan McCoy MD Named Chief Medical Officer at Catapult Health

Catapult’s forward-looking innovation and leadership in virtual clinical care were key drivers in bringing McCoy and Michel together

Dan McCoy MD will provide clinical and strategic leadership to the company as he joins Catapult’s executive team.

Dr. McCoy is a physician, entrepreneur, and communicator who is passionate about improving the way healthcare is delivered. In his time as president of Blue Cross and Blue Shield of Texas, he was instrumental in the creation of the C1 Innovation Lab in Dallas, with the goal of uniting clinicians, members, advocates, and innovators to work together to generate solutions. Dr. McCoy’s previous roles at BCBSTX included divisional senior vice president of the Texas market strategy, and Texas plan chief medical officer. During his term as president (2016-2020), BCBSTX experienced the largest growth in membership, underwriting margin and revenue in the company’s 90-year history.

“I’m excited about the opportunity to contribute to the already great work of Catapult Health,” said Dr. McCoy. “I’ve watched them from their early days and have always been impressed with how well they’ve focused on the patient, while being nimble and responsive to major changes in the healthcare environment.”

“I’ve known and worked with Dr. McCoy for the better part of a decade, and now is the perfect time for him to join our team,” said Michel. “Over the past year, we created and launched the nation’s first VirtualCheckup®, leveraging our world-class clinical expertise, sophisticated technology, and ability to scale up quickly. Dr. McCoy’s skills and experiences are very well matched with our go-forward strategy.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The AGENT DCB is available in Europe, parts of Asia Pacific and Latin America for the treatment of patients with ISR and previously untreated small vessel coronary disease. Boston Scientific plans to launch the technology in the U.S. in the coming months.
Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy